Sponsor & Developer Portfolio
Bandim Health Project
Clinical development pipeline, platform architecture, and registered trial tracking for Bandim Health Project vaccine candidates.
2
Candidates
2
Target Diseases
3
Linked Studies
Development Phase Distribution
Discontinued / Inactive: 1 Phase 3 Clinical Trial: 1
Platform Technologies
Biological (unspecified platform): 2
Target Pathogens & Indications
Measles / Mumps / Rubella Tuberculosis
Vaccine Pipeline Candidates (2)
Detailed candidate profiles, clinical phases, target indications, and anticipated milestones.
Discontinued / Inactive
ctgov-bcg-denmark-1331-statens-serum-institute-bandim-health-project
BCG-Denmark 1331 (Statens Serum Institute)
Target: Tuberculosis
Platform: Biological (unspecified platform)
Key Milestone: Primary completion (most advanced trial): 2021-06 (registry estimate)
Phase 3 Clinical Trial
ctgov-bcg-vaccine-bandim-health-project
BCG vaccine
Target: Measles / Mumps / Rubella
Platform: Biological (unspecified platform)
Key Milestone: Primary completion (most advanced trial): 2025-12-31 (registry estimate)
Explore Other Vaccine Developers & Sponsors
Compare pipeline volume, phase progression, and modalities across global biopharmaceutical manufacturers.